Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats DOI
Fatma H. Rizk, Amira A. El Saadany, Amira M. Elshamy

и другие.

The Journal of Physiology, Год журнала: 2024, Номер 602(15), С. 3621 - 3639

Опубликована: Июль 9, 2024

Growing evidence supports the role of gut microbiota in chronic inflammation, insulin resistance (IR) and sex hormone production polycystic ovary syndrome (PCOS). Adropin plays a pivotal regulation glucose lipid metabolism is negatively correlated with IR, which affects intestinal hormones. However, effect adropin administration PCOS has yet to be investigated. The present study aimed assess effects on letrozole (LTZ)-induced rats potential underlying mechanisms. experimental groups were normal, adropin, LTZ + adropin. At end experiment, significantly ameliorated PCOS, as evidenced by restoring normal ovarian structure, decreasing theca cell thickness antral follicles, well serum testosterone luteinizing levels hormone/follicle-stimulating ratios, at same time increasing granulosa oestradiol follicle-stimulating levels. ameliorating could attributed its hormone-binding globulin, key steroidogenic genes STAR CYP11A1, profile, metabolites-brain-ovary axis components (short chain fatty acids, free acid receptor 3 peptide YY), permeability marker (zonulin tight junction protein claudin-1), lipopolysaccharides/Toll-like 4/nuclear factor kappa B inflammatory pathway oxidative stress makers (malondialdehyde total antioxidant capacity). In conclusion, promising therapeutic regulating steroidogenesis, redox homeostasis. KEY POINTS: treatment reversed endocrine morphology disorders regulated steroidogenesis globulin PCOS. improved profile decreased modulated gut-brain-ovary YY) barrier integrity, suppressed signalling

Язык: Английский

Polycystic Ovary Syndrome Pathophysiology: Integrating Systemic, CNS and Circadian Processes DOI Creative Commons
George Anderson

Frontiers in Bioscience-Landmark, Год журнала: 2024, Номер 29(1), С. 24 - 24

Опубликована: Янв. 18, 2024

The conceptualization of polycystic ovary syndrome (PCOS) has primarily focused on hormonal alterations driven by changes within the hypothalamus and ovarian granulosa cells, with treatment contraceptive pill weight loss. However, a growing body data implicates wider systemic central nervous system (CNS) in pathoetiology pathophysiology PCOS, consequent implications for targeted treatments. It is proposed that there significant role night-time interactions factors acting to regulate whether rising level cortisol over night during morning awakening response (CAR) able induce nuclear translocation glucocorticoid receptor (GR), thereby influencing how immune glial systems cellular function preparation coming day. Factors affording protection PCOS also inhibit GR including gut microbiome-derived butyrate, pineal/local melatonin as well regulated bcl2-associated athanogene (BAG)-1. A pathophysiological attributed aryl hydrocarbon (AhR), which shows heightened levels activity PCOS. AhR activated ligands many processes, white adipocyte-derived kynurenine, implicating obesity occurring ovaries. activation consequences physiological hypothalamic paraventricular nucleus, cells adipocytes, partly mediated upregulation mitochondrial N-acetylserotonin/melatonin ratio, decreasing availability whilst increasing local stress plasticity nucleus. This article reviews detail CNS highlighting pineal melatonergic pathway, nucleus tanycytes/astrocytes, hypothalamus-pituitary-adrenal (HPA) axis pathophysiology. integrates wide array previously disparate biological underpinnings associates other currently classified medical conditions, such depression, bipolar disorder, type 1 diabetes mellitus autism spectrum. Numerous future research are detailed.

Язык: Английский

Процитировано

3

Differential enrichment of bacteria and phages in the vaginal microbiomes in PCOS and obesity: shotgun sequencing analysis DOI Creative Commons

Senlin Zheng,

Huimin Chen,

Hongyi Yang

и другие.

Frontiers in Microbiomes, Год журнала: 2024, Номер 2

Опубликована: Март 26, 2024

Introduction Previous research has linked vaginal bacteria to polycystic ovary syndrome (PCOS) and obesity in women, yet the specific disparities microbiota between these conditions remain unclear. Methods In this study, we aimed elucidate contribution of dysregulated PCOS by analyzing reproductive-aged women with without PCOS, as well obese non-obese using shotgun sequencing. Results Swab specimens were collected from four groups subjects: obese, non-obese, non-PCOS non-obese. A total 333 24 viruses/phages identified species level. Clustering analysis revealed that individuals exhibit a similar “healthy” microbiome, while both associated microbial dysbiosis. Significant differences abundance observed for 26 bacterial 6 phages/viruses groups. Notably, pathobionts such Streptococcus pyogenes , Leptospira santarosai Citrobacter amalonaticus Listeria ivanovii Clostridium perfringens significantly less abundant or absent group. Furthermore, Lactobacillus Pseudomonas bacteria, their corresponding phages exhibited positive correlations. lactobacillus phage, pseudomonas phage/virus indicators healthy microbiome. Importantly, differentially enriched distinct. Discussion This study confirms are differing enrichment viruses/phages, Moreover, our findings suggest phage diversity is microbiota, dysbiosis decrease alongside increased diversity.

Язык: Английский

Процитировано

3

Polycystic ovary syndrome: Insights into its prevalence, diagnosis, and management with special reference to gut microbial dysbiosis DOI
Nisha H. Khobragade, Devang Sheth, Chirag Patel

и другие.

Steroids, Год журнала: 2024, Номер 208, С. 109455 - 109455

Опубликована: Июнь 13, 2024

Язык: Английский

Процитировано

3

Inositol Restores Appropriate Steroidogenesis in PCOS Ovaries Both In Vitro and In Vivo Experimental Mouse Models DOI Creative Commons
Valeria Fedeli, Vittorio Unfer, Simona Dinicola

и другие.

Cells, Год журнала: 2024, Номер 13(14), С. 1171 - 1171

Опубликована: Июль 9, 2024

Androgen excess is a key feature of several clinical phenotypes polycystic ovary syndrome (PCOS). However, the presence FSH receptor (FSHR) and aromatase (CYP19A1) activity responses to physiological endocrine stimuli play critical role in pathogenesis PCOS. Preliminary data suggest that myo-Inositol (myo-Ins) D-Chiro-Inositol (D-Chiro-Ins) may reactivate CYP19A1 activity. We investigated steroidogenic pathway Theca (TCs) Granulosa cells (GCs) an experimental model murine PCOS induced CD1 mice exposed for 10 weeks continuous light regimen. The effect treatment with different combinations myo-Ins D-Chiro-Ins on expression Fshr, androgenic, estrogenic enzymes was analyzed by real-time PCR isolated TCs GCs ovaries from healthy mice. Myo-Ins D-Chiro-Ins, at ratio 40:1 pharmacological concentrations, positively modulate Cyp19a1 Fshr GCs. Moreover, vivo, inositols (40:1 ratio) significantly increase Fshr. These changes gene are mirrored modifications hormone levels serum treated animals. formula efficiently rescued features up-regulating FSHR while down-regulating androgen excesses produced TCs.

Язык: Английский

Процитировано

3

Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats DOI
Fatma H. Rizk, Amira A. El Saadany, Amira M. Elshamy

и другие.

The Journal of Physiology, Год журнала: 2024, Номер 602(15), С. 3621 - 3639

Опубликована: Июль 9, 2024

Growing evidence supports the role of gut microbiota in chronic inflammation, insulin resistance (IR) and sex hormone production polycystic ovary syndrome (PCOS). Adropin plays a pivotal regulation glucose lipid metabolism is negatively correlated with IR, which affects intestinal hormones. However, effect adropin administration PCOS has yet to be investigated. The present study aimed assess effects on letrozole (LTZ)-induced rats potential underlying mechanisms. experimental groups were normal, adropin, LTZ + adropin. At end experiment, significantly ameliorated PCOS, as evidenced by restoring normal ovarian structure, decreasing theca cell thickness antral follicles, well serum testosterone luteinizing levels hormone/follicle-stimulating ratios, at same time increasing granulosa oestradiol follicle-stimulating levels. ameliorating could attributed its hormone-binding globulin, key steroidogenic genes STAR CYP11A1, profile, metabolites-brain-ovary axis components (short chain fatty acids, free acid receptor 3 peptide YY), permeability marker (zonulin tight junction protein claudin-1), lipopolysaccharides/Toll-like 4/nuclear factor kappa B inflammatory pathway oxidative stress makers (malondialdehyde total antioxidant capacity). In conclusion, promising therapeutic regulating steroidogenesis, redox homeostasis. KEY POINTS: treatment reversed endocrine morphology disorders regulated steroidogenesis globulin PCOS. improved profile decreased modulated gut-brain-ovary YY) barrier integrity, suppressed signalling

Язык: Английский

Процитировано

3